Compounds > bupivacaine

bupivacaine and phencyclidine

bupivacaine has been researched along with phencyclidine in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (42.86)18.2507
2000's3 (42.86)29.6817
2010's1 (14.29)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bruno-Blanch, L; Gálvez, J; García-Domenech, R1
Lombardo, F; Obach, RS; Waters, NJ1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV1
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV1
Kimura, I; Kimura, M; Muroi, M; Nojima, H1
Kimura, I; Kimura, M; Kondoh, T; Tsuneki, H2

Other Studies

7 other study(ies) available for bupivacaine and phencyclidine

ArticleYear
Topological virtual screening: a way to find new anticonvulsant drugs from chemical diversity.
    Bioorganic & medicinal chemistry letters, 2003, Aug-18, Volume: 13, Issue:16

    Topics: Anticonvulsants; Computer Simulation; Databases, Factual; Discriminant Analysis; Drug Design; Molecular Structure; Quantitative Structure-Activity Relationship

2003
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Physicochemical determinants of human renal clearance.
    Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15

    Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight

2009
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
    Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3

    Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations

2010
Mechanism of the blocking action of beta-eudesmol on the nicotinic acetylcholine receptor channel in mouse skeletal muscles.
    Neuropharmacology, 1991, Volume: 30, Issue:8

    Topics: Animals; Bupivacaine; Chlorpromazine; Drugs, Chinese Herbal; Male; Membrane Potentials; Mice; Motor Endplate; Muscles; Phencyclidine; Receptors, Nicotinic; Sesquiterpenes, Eudesmane; Terpenes

1991
Noncontractile acetylcholine receptor-operated Ca++ mobilization: suppression of activation by open channel blockers and acceleration of desensitization by closed channel blockers in mouse diaphragm muscle.
    The Journal of pharmacology and experimental therapeutics, 1991, Volume: 256, Issue:1

    Topics: Aequorin; Animals; Anti-Ulcer Agents; Bupivacaine; Calcium; Calcium Channel Blockers; Chlorpromazine; Cholinergic Antagonists; Diaphragm; Male; Mice; Muscle Contraction; Muscle, Smooth; Neostigmine; Nicotinic Antagonists; Peptides, Cyclic; Phencyclidine; Receptors, Cholinergic; Receptors, Nicotinic; Sesquiterpenes, Eudesmane; Sodium; Terpenes

1991
Enhancing effect by nicotinic acetylcholine receptor channel blockers, including beta-eudesmol, on succinylcholine-induced inhibition of twitch tension and intracellular Ca++ in mouse diaphragm muscle.
    The Journal of pharmacology and experimental therapeutics, 1991, Volume: 256, Issue:1

    Topics: Aequorin; Animals; Bupivacaine; Calcium; Chlorpromazine; Diaphragm; Dose-Response Relationship, Drug; Male; Mice; Mice, Inbred Strains; Muscle Contraction; Muscle, Smooth; Nicotinic Antagonists; Pancuronium; Phencyclidine; Sesquiterpenes, Eudesmane; Succinylcholine; Terpenes; Time Factors

1991